Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
US7186699B2 · kind B2 · utility
19Cited by
19References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2004 |
| Grant date | Mar 6, 2007 |
| Priority date | — |
| Expiry date | Jun 14, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides therapeutic compositions and methods for vector-mediated delivery and in vivo expression of polynucleotides encoding anti-cancer compounds that are effective in the treatment of cancer. In particular, the invention relates to the use of recombinant viral and non-viral vectors to deliver genes encoding one or more anti-angiogenic or proapoptotic gene products for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.